Vext Science, Inc.
VEXT
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.83M | 44.15M | 39.17M | 36.00M | 34.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.83M | 44.15M | 39.17M | 36.00M | 34.22M |
| Cost of Revenue | 34.58M | 30.89M | 29.23M | 27.01M | 25.50M |
| Gross Profit | 13.25M | 13.25M | 9.94M | 8.99M | 8.72M |
| SG&A Expenses | 11.03M | 11.00M | 11.12M | 11.44M | 16.09M |
| Depreciation & Amortization | 9.21M | 9.06M | 8.90M | 8.74M | 8.58M |
| Other Operating Expenses | 328.10K | 328.10K | 328.10K | 374.00K | -1.00K |
| Total Operating Expenses | 55.14M | 51.28M | 49.58M | 47.55M | 50.16M |
| Operating Income | -7.31M | -7.13M | -10.41M | -11.55M | -15.94M |
| Income Before Tax | -13.36M | -13.22M | -18.00M | -21.12M | -5.99M |
| Income Tax Expenses | 3.30M | 3.30M | 1.43M | 1.31M | 1.60M |
| Earnings from Continuing Operations | -16.65 | -16.52 | -19.43 | -22.43 | -7.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.65M | -16.52M | -19.43M | -22.43M | -7.59M |
| EBIT | -7.31M | -7.13M | -10.41M | -11.55M | -15.94M |
| EBITDA | 7.48M | 7.50M | 3.92M | 2.84M | -1.85M |
| EPS Basic | -0.07 | -0.07 | -0.08 | -0.09 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.05 | -0.05 | -0.05 |
| EPS Diluted | -0.07 | -0.07 | -0.08 | -0.10 | -0.03 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.05 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 990.13M | 988.07M | 985.94M | 963.58M | 925.27M |
| Average Diluted Shares Outstanding | 990.13M | 991.17M | 989.04M | 966.91M | 929.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |